Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Huge rise in antibiotic incentive schemes

By Lilian Anekwe

Exclusive: Half of PCTs are now running incentive schemes to cut GP antibiotic prescribing rates- with 40% of them set up in the past year - as trusts desperately try to tackle rising rates of antimicrobial resistance, a Pulse investigation has found.

The news comes as the first solid evidence linking antibiotic prescribing with resistance levels in the community emerges.

Responses to a Freedom of Information request from 116 English PCTs reveal that 56, or 48%, have such schemes with 40% set up in the past year as a direct response to concerns about rising antibiotic resistance.

Much of the focus is on broad-spectrum antibiotics like co-amoxiclav, cephalosporins, and quinolones – all linked to the rise in healthcare-associated infections Clostridium difficile and MRSA .

But macrolide antibiotics, including azithromycin – approved last year by the MHRA for sale over the counter – are also targeted in some schemes.

Some trusts are even insisting on a ‘no antibiotic or delayed antibiotic policy' for conditions such as respiratory tract infections, cough and bronchitis.

The scale of the clampdown emerged as results from a systematic review of 29 primary care studies were presented at the Society for Academic Primary Care meeting.

Researchers found the odds of a resistant infection were increased by 93% if patients had a prior prescription for a respiratory tract infection, and by 26% for prior antibiotics for urinary tract infections.

Overall, researchers found a clear ‘dose-response relationship', with one previous antibiotic course making it 2.5 times more likely for the patient to have a resistant infection and 3.4 times more likely after three or more previous courses.

The findings of the Pulse investigation divided opinion among GP experts. Dr Peter Fellowes, a member of the GPC's prescribing subcommittee and a GP in Lydney, Gloucestershire, said: ‘I think it's immoral to use financial incentive schemes in this way. It's a matter of education, not incentives.'

Professor Chris Butler, professor of primary care medicine at the University of Cardiff and a GP in Mountain Ash, Glamorgan, defended GPs. He told Pulse: ‘Many GPs are trying to keep patients out of hospital – in their mind they may be doing it for the right reasons.

‘Financial incentives might help with the easy cases. But for the real challenges what we need is better evidence – not just dangling financial incentives. This isn't the right way to change practice.'

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say